Xavier Paolettí
Xavier Paolettí publishes mostly in Oncology, Statistics and Probability and Pulmonary and Respiratory Medicine, on topics such as Statistical Methods in Clinical Trials, Cancer Genomics and Diagnostics and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #318,614 of 7,710,434 ranked researchers
- Rank in France
- #18,227 of 324,115
- Works
- 302
- Citations
- 8.7k
- Citations per work
- 28.9
What does Xavier Paolettí research?
Xavier Paolettí's work is mostly in Medicine (31%), Mathematics (16%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else12140.2%
- Health Sciences9330.8%
- Medicine9330.8%
- Physical Sciences4916.1%
- Mathematics4916.1%
- Life Sciences227.3%
- Social Sciences175.6%
- 1Oncology16% of their works
- 2Statistics and Probability16% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Cancer Research7% of their works
- 5Surgery7% of their works
- 6Economics and Econometrics6% of their works
Research topics
- Statistical Methods in Clinical Trials
- Cancer Genomics and Diagnostics
- Health Systems, Economic Evaluations, Quality of Life
- Ovarian cancer diagnosis and treatment
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Advanced Causal Inference Techniques
- PARP inhibition in cancer therapy
Which keywords describe Xavier Paolettí's research?
The keywords of their largest research topics: Biomarkers, Adaptive Designs, False Discovery Rate, Targeted Therapy, Chemotherapy, Clinical Trials, Cancer Genomics and Mutational Signatures.
- Propensity Score
- Causal Inference
- EGFR Mutations
- KRAS Mutations
- Ovarian Cancer
- Quality of Life
- Mutational Signatures
- Clinical Trials
- Targeted Therapy
- Adaptive Designs
- Biomarkers
- False Discovery Rate
- Chemotherapy
- Cancer Genomics
- Cost-effectiveness Analysis
- Genomic Analysis
- Cetuximab
- ALK Inhibitors
- BRCA Mutation
- PARP Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Biomarkers1282 topics
- Adaptive Designs961 topic
- False Discovery Rate961 topic
- Targeted Therapy712 topics
- Chemotherapy582 topics
- Clinical Trials532 topics
- Cancer Genomics501 topic
- Mutational Signatures501 topic
- Cost-effectiveness Analysis411 topic
- Quality of Life411 topic
- Genomic Analysis321 topic
- Ovarian Cancer321 topic
- Cetuximab261 topic
- KRAS Mutations261 topic
- ALK Inhibitors211 topic
- EGFR Mutations211 topic
- BRCA Mutation201 topic
- Causal Inference201 topic
- PARP Inhibitors201 topic
- Propensity Score201 topic
Where does Xavier Paolettí work?
Xavier Paolettí's main affiliation in the publication record is Institut Curie, France.
How many publications and citations does Xavier Paolettí have?
OpenAlex counts 302 works and 8,732 citations for Xavier Paolettí, an h-index of 50, ranking #318,614 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Xavier Paolettí. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.